WA
LSBPW

Whitebox Advisors’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Whitebox Advisors’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-125,000
Closed -$4.99K – 465
2025
Q2 		$4.99K Hold
125,000
– – ﹤0.01% 361
2025
Q1 		$5.15K Hold
125,000
– – ﹤0.01% 281
2024
Q4 		$9.93K Hold
125,000
– – ﹤0.01% 221
2024
Q3 		$8.26K Hold
125,000
– – ﹤0.01% 218
2024
Q2 		$11K Hold
125,000
– – ﹤0.01% 218
2024
Q1 		$8.95K Hold
125,000
– – ﹤0.01% 217
2023
Q4 		$4.75K Hold
125,000
– – ﹤0.01% 214
2023
Q3 		$5.15K Hold
125,000
– – ﹤0.01% 248
2023
Q2 		$5.88K Hold
125,000
– – ﹤0.01% 282
2023
Q1 		$19.5K Buy
+125,000
New +$18.9K ﹤0.01% 303

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Whitebox Advisors's LSBPW Position: Q3 2025 in Review

Whitebox Advisors sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 125,000 shares — an estimated $4.99K sold.

Whitebox Advisors first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $19.5K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • Whitebox Advisors reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Whitebox Advisors sold 125,000 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $4.99K.
  • Whitebox Advisors first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
  • Whitebox Advisors's LakeShore Biopharma Warrants position peaked at $19.5K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Whitebox Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.